Back to search
FDAFDA · Food and drugs·Recall number D-0539-2023

Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05

Published April 26, 2023 · Recall initiated: March 17, 2023

Summary

FDA records drug Class II recall D-0539-2023, published April 26, 2023 and initiated March 17, 2023. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 135 bottles; Lot: Lot #22143120, Exp. Date: June 2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Out of specification (OOS) for Spectroscopic Identification test by IR.

What to do

Voluntary: Firm initiated · Letter

Get an email if ARIPIPRAZOLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ARIPIPRAZOLE
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide in the USA
Lot
Lot #22143120, Exp. Date: June 2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05 recalled?

Yes. FDA published recall D-0539-2023 on April 26, 2023. Reported hazard: Out of specification (OOS) for Spectroscopic Identification test by IR.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ARIPIPRAZOLE.